Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice-Reference-Cited by-同舟云学术

Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice

Published:2021-12 Issue: Volume:169 Page:211-219
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Ozgür Burak,Saaby Lasse,Janfelt Christian,Langthaler Kristine,Eneberg Elin,Jacobsen Anne-Marie,Badolo Lassina,Montanari Dino,Brodin Birger

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference46 articles.

1. CNS drug design: balancing physicochemical properties for optimal brain exposure;Rankovic;J. Med. Chem.,2015

2. Demystifying brain penetration in central nervous system drug discovery. Miniperspective;Di;J. Med. Chem.,2013

3. The Caco-2 cell monolayer: usefulness and limitations;Sun;Expert Opin Drug Metab Toxicol,2008

4. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2;Mease;J. Pharm. Sci.,2012

5. Cell cultures as tools in biopharmacy;Braun;Eur. J. Pharm. Sci.,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Screening System for Biliary Excretion of Drugs Using Human Cholangiocyte Organoid Monolayers with Directional Drug Transport;Biological and Pharmaceutical Bulletin;2024-02-16

2. Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution;Fluids and Barriers of the CNS;2024-01-25

3. Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution.;2023-09-01

4. Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathway;Bioengineered;2022-05-02

5. Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development;Pharmaceutical Research;2022-04-11